


Epigenetic Stability Linked to Lifespan in Mammals, Research Show
Introduction The recent study published in the journal Science Advances on

Orna Therapeutics Acquires ReNAgade Therapeutics to Enhance RNA Medicine Development
Orna Therapeutics, a Massachusetts-based biotech firm specializing in circular RNA

AstraZeneca Completes Equity Investment in Cellectis to Enhance Gene Therapy Development
AstraZeneca has completed its planned equity investment in Cellectis, a

Innovative Breakthrough in Genomics: Profluent’s OpenCRISPR-1 Revolutionizes Human Genome Editing
In a groundbreaking achievement, the biotechnology firm Profluent has successfully
